Pediatric Oncology

Pediatric Oncology Prevalence and Classification of Anemia among Children in Sudan: A Systematic Review And Meta-Analysis
Mubarak Ibrahim Idriss • Ibrahim Khidir Ibrahim • Khalid Hajissa
doi.org/10.69690/ODMJ-018-0425-2940
Pediatric Oncology MTHFR A1298C Polymorphism: A Potential Marker for B-ALL Prognosis in Sudanese Pediatric Patients
Idriss Hamid • Ibrahim Khidir Ibrahim • Mahdi H. A. Abdalla
doi.org/10.69690/ODMJ-018-0425-2935
Pediatric Oncology Importance of psychosocial support in enhancing mental health and quality of life in pediatric cancer patients
Kamila Askarova • Malikakhon Shukurova
doi.org/10.69690/ODMJ-018-0425-2491
Pediatric Oncology Use of Cabozantinib in addition to chemotherapy as a viable second line treatment option in Relapsed Refractory Malignant Osteogenic Sarcomas
Dale Jude Montes • Maharshi Trivedi • Helie Raval • Himangi Tak • Chinmay Doctor • Harsha Panchal
doi.org/10.69690/ODMJ-018-0425-2488
Pediatric Oncology Pediatric Lymphoblastic Lymphoma: Clinical course, challenges and treatment strategies
Ruksana Sidhique • Nikita Jakhar • Sharan Shanubhogue • Jagdish Prasad Meena • Aditya Kumar Gupta
doi.org/10.69690/ODMJ-018-0425-2477
Pediatric Oncology Elevated Procalcitonin and Proadrenomedullin Levels at Diagnosis and During Febrile Neutropenia in Pediatric Acute Leukemia: A Prospective Study from a Tertiary Care Center
Ruksana Sidhique • Jagdish Prasad Meena • Harshita Makkar • Aditya Kumar Gupta • Ashutosh Halder • Rachna Seth
doi.org/10.69690/ODMJ-018-0425-2475
Pediatric Oncology Pediatric desmoid fibromatosis – Experience from a tertiary care cancer hospital
Dale Jude Montes • Maharshi Trivedi • Helie Raval • Chinmay Doctor • Harsha Panchal
doi.org/10.69690/ODMJ-018-0425-2471
Pediatric Oncology NCI Standard risk B-cell Acute Lymphoblastic Leukemia – Ten year outcome from India. Where are we heading towards?
Annapoorani Ramasamy • Venkateshwaran VS
doi.org/10.69690/ODMJ-018-0425-2468
Pediatric Oncology Profile of neuroblastoma – experience from a tertiary paediatric oncology centre from a developing country
Rishab Bhurat • Mohanaraj Ramachandran • Julius Scott • Ashwini Arul • Latha M. Sneha • Madhu S • Satish Srinivas • Rajeswaran Rangasami • Leena Dennis Joseph
doi.org/10.69690/ODMJ-018-0425-2457
Pediatric Oncology Belumosudil is effective in Pediatric Patients with chronic Graft-versus-Host disease after failed Ruxolitinib treatment
Yuanyuan Chen • Xiaojun Xu • Fenfen Jin
doi.org/10.69690/ODMJ-018-0425-2454
Pediatric Oncology B-cell precursor Acute Lymphoblastic Leukemia with high hyperdiploidy who have detectable residual disease at the end of induction can be salvaged by treatment escalation
Aniruddha Rathore • Chetan Dhamne • Nirmalya Roy Moulik • Shyam Srinivasan • Akanksha Chichra • Vikramraj Gokhale • Ruchika Gavanang • Shripad Banavali • Gaurav Narula
doi.org/10.69690/ODMJ-018-0425-2439
Pediatric Oncology Treatment outcomes and late effects in Retinoblastoma survivors: Importance of survivor clinics
Rachna Seth • Bhavna Chawla
doi.org/10.69690/ODMJ-018-0425-2426